Applied Quantum Chemistry for Oncology
The Triplet Team
Triplet State Technology has a core team of first-tier researchers, clinicians, and innovation specialists uniquely qualified to develop the patent to clinical application.
- All
- Scientific Advisory Board
- Engineering
- Founder
- Corporate Management
- Management Advisory Board
Scientific Advisory Board, Founder, Corporate Management, Management Advisory Board
CEO, Founder
Dr. Sandstrom completed his M.D. at the University of Washington, Seattle, WA in 1971. He has since received an MBA from the UC, Irvine in 1998 and a MA in the History of Science and Technology at the University of London in 2012. Dr. Sandstrom has been a visiting researcher at the Wellcome Sanger Center for Genomics in Hinxton, UK and a visiting member of Darwin College, Cambridge. Dr. Sandstrom completed an internship at Toronto General Hospital and Toronto Sick Children’s Hospital. He completed a residency at Massachusetts General Hospital in Boston. He was a clinical fellow at Harvard University Medical School. Dr. Sandstrom received a meritorious service medal while serving as a Lieutenant Commander in the USPHS.
Scientific Advisory Board, Management Advisory Board
Scientific Advisor, Investor
Dr. Mark Legaz received a Ph.D. in biochemistry from the University of Washington in Seattle, and did his post doctoral research in clinical chemistry at the University of Washington. He is the President and CEO of Intersect Systems, Inc., a medical diagnostic products company. Mark also founded and is a consultant to Catch, Inc, of Seattle, Washington, whose diagnostic technologies were acquired by Axis-Shield of Scotland.
Corporate Management
Chief Operating Officer, Consultant
Dr. Strause is the Principal and Founder of Strategic Clinical Consultants. She brings over 35 years of expertise in global clinical operations and clinical development, with emphasis in oncology and ethical considerations for subjects with life-threatening disease. Dr. Strause consults for the biotechnology industry on clinical development and operation strategies and is considered an expert in oncology programs.
Dr. Strause has been an Adjunct Professor appointment at the University of California, San Diego for over 30 yrs, where she teaches an Introduction to Human Nutrition course to undergraduates.
Corporate Management, Management Advisory Board
Chief Strategy Officer, Consultant
Mr. McQueen is a highly experienced and accomplished business and executive consultant who brings a profound emphasis on achieving balanced and rapid structured growth. With an impressive career spanning over three decades, he has excelled in providing private coaching, specializing in growth strategies, marketing, technology, and team engagement. Mark has successfully forged strategic alliances, cultivated high-performing teams, and implemented streamlined systems. Mark has been honored with esteemed awards and holds certifications across various domains. He is widely acknowledged for his exceptional leadership, astute strategic oversight, and remarkable problem-solving acumen.
Scientific Advisory Board
In 1984, Dr. William McBride became a professor of radiation oncology at UCLA. In 1987, he earned his D.Sc. from University of Edinburgh. He is currently the co-leader of the UCLA Center for Medical Countermeasures Against Radiation (CMCR), a NIAID supported program focused on radiation mitigation research. Dr. William McBride research includes the effects of radiation on degradation of proteins and its implications in the development of tumor immunity. Publications
Scientific Advisory Board
In 1988, Dr. Low received a PhD in Physics from Indiana University. He later was a postdoctoral fellow in radiation therapy physics for two years at M.D. Anderson Cancer Center. Dr. Low moved to UCLA in 2010 as the Vice Chair and Director of Medical Physics. In 2023 he was promoted to Professor and Vice Chair of Medical Physics Research and Innovation. His research interests include modeling of human breathing motion, radiation therapy safety, quality assurance methods, image-guided radiation therapy including magnetic resonance-image guided radiation therapy.
Scientific Advisory Board
Dr. Iwamoto is a professor at the UCLA Department of Radiation Oncology. He obtained his PhD at UCLA in 1990. A central component of his research is the biological mechanisms of radiation response, especially carcinogenesis, and their exploitation in improvement of radiotherapy. Publications
Scientific Advisory Board
Sr. Consultant Regulatory, Quality Assurance matter
Robert J. Morton, Jr., M.S. serves as Triplet State Technologies Senior Consultant in Regulatory and Quality Assurance matters. A Board-certified Radiological Physicist with over 50 years of relevant experience, Bob is President of Quality and Regulatory Services, Inc. (QRS). He provides our team with in-depth and expert guidance concerning device clearance and other FDA requirements and brings with him a wealth of medical device application experience as well.
Management Advisory Board
Legal Counsel
Karl Sandstrom is a nationally recognized authority on election law and a former Federal Elections Commissioner. Mr. Sandstrom received his J.D. from George Washington University and completed a LL.M. in tax law from Georgetown University. Karl is Senior Counsel in the Perkins Coie Washington D.C. Office. Karl has appeared on national radio and television programs including Good Morning America, CBS News, NPR and the PBS Newshour. His articles have appeared in national publications including the New York Times and Washington Post. Karl has been an advisor to Triplet State Technology from inception.
Management Advisory Board
Advisor
Using his entrepreneurial skills, Dick has been instrumental in bringing about innovative technologies that promote and improve quality of life for humankind. Over the past forty-seven years he has successfully founded, directed, and exited companies within the medical technology arena. He continues to consult with companies regarding design and manufacture of medical products with disruptive technologies.
